HOME >> BIOLOGY >> NEWS
New tuberculosis antibiotic may shorten treatment time, fight drug-resistant strains

This release is also available in French.

A new antibiotic shows promise, thus far in mice, for treating tuberculosis much faster than current drugs do, scientists report. Additional evidence indicates that the antibiotic may work against multidrug-resistant strains of the tuberculosis bug. Studies in healthy human volunteers have indicated that the drug is safe for humans to take, and further human studies are currently underway.

These findings, by Koen Andries of Johnson & Johnson Pharmaceutical Research and Development, LLC in Beerse, Belgium and colleagues, will appear online in the 9 December Science Express, part of the journal Science, published by AAAS, the nonprofit science society.

Globally, tuberculosis is second only to AIDS as a leading cause of death from infectious disease, causing approximately two million deaths per year. The tuberculosis and HIV epidemics fuel one another; at least 11 million adults are infected with both pathogens, according to the Global Alliance for TB Drug Development.

No new tuberculosis-specific drugs have been discovered in the last 40 years, and emerging strains of the bacterium that are resistant to multiple drugs are an increasingly worrisome problem. The current treatment for drug-sensitive tuberculosis recommended by the World Health Organization consists of a cocktail of drugs that must be taken for six to nine months.

"The world desperately needs a new tuberculosis drug that can combat resistant strains of the bacterium and that is easier for patients to take. The evidence thus far suggests that this new drug lead may be up to both tasks, which is encouraging news for global health," said Katrina Kelner, Deputy Editor, life sciences, at Science.

"If this drug is ultimately approved for humans, it could lead to a change in treatment paradigm for tuberculosis," Andries said.

The dr
'"/>

Contact: Jessica Lawrence-Hurt
jlawrenc@aaas.org
1-202-326-7088
American Association for the Advancement of Science
9-Dec-2004


Page: 1 2 3 4

Related biology news :

1. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
2. Handicapping tuberculosis may be the way to a better vaccine
3. Developing a more effective vaccine for tuberculosis
4. Why is long-term therapy required to cure tuberculosis?
5. UA researchers identify new adherence factor, Pili, produced by tuberculosis
6. Shorter tuberculosis therapies could lead to substantial reductions in cases and deaths
7. Pitt phage hunter takes on tuberculosis
8. Cost-effectiveness of treating multidrug-resistant tuberculosis
9. New potential drug target in tuberculosis
10. National Institutes of Health funds $13.7 million for Texas tuberculosis study
11. Einstein researchers find potential new drugs for tuberculosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/2/2019)... ... January 31, 2019 , ... Pharmica Consulting announced ... operations executives and focusing on all facets of clinical trial planning and management. ... management, resource management, patient engagement, and more. , “We have attended the ...
(Date:2/2/2019)... , ... February 01, 2019 , ... ... Accreditation for Clinical Testing Laboratories by A2LA, which establishes requirements for medical laboratories ... standard. The laboratory is already CLIA-licensed as well as College of American Pathologists ...
(Date:1/25/2019)... ... January 24, 2019 , ... GrowthZone, Inc., ... Survey. The report indicates membership growth in some sectors and decreasing membership among ... received responses from over 500 association professionals across North America. , “This ...
Breaking Biology News(10 mins):
(Date:1/20/2019)... ... 17, 2019 , ... Consumers are directing healthcare in many ... That's changing as many services now exist for patients to order tests without ... $208 million in 2018, according to Kalorama Information’s new report, The Direct-To-Consumer ...
(Date:1/15/2019)... BROOK, Ill. (PRWEB) , ... January 15, 2019 , ... ... risk factors for worsening kidney disease, according to a new study published in the ... stage and are frequently treated with partial nephrectomy, a surgical procedure in which the ...
(Date:1/10/2019)... ... ... a local shelter when he was around two years old. According to his mom, ... was adopted, he tore his right cruciate ligament. Though he had his ACL surgically ... injury. , Sure enough, when Rascal was about nine years old, he began showing symptoms ...
(Date:1/8/2019)... ... 2019 , ... The American Society of Gene and Cell Therapy’s ... committee made up of industry leaders identified by the ASGCT board of directors. In ... created to support ASGCT members designing transformative pilot studies in gene and cell therapy ...
Breaking Biology Technology:
Cached News: